Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 45.69 USD 3.58% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Gross Margin
Omnicell Inc

41.4%
Current
45%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
441m
/
Revenue
1.1B

Gross Margin Across Competitors

Country US
Market Cap 2.1B USD
Gross Margin
41%
Country US
Market Cap 35B USD
Gross Margin
73%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 23.2B AUD
Gross Margin
100%
Country US
Market Cap 9B USD
Gross Margin
90%
Country JP
Market Cap 967.6B JPY
Gross Margin
58%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Country US
Market Cap 5.4B USD
Gross Margin
67%
Country SE
Market Cap 53.1B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.4B CNY
Gross Margin
43%
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

OMCL Intrinsic Value
44.14 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
441m
/
Revenue
1.1B
What is the Gross Margin of Omnicell Inc?

Based on Omnicell Inc's most recent financial statements, the company has Gross Margin of 41.4%.